This study showed the positive relationship between c-Myc expression in highly metastatic human prostate and colon cancer cells and susceptibility to TRAIL-induced apoptosis, which indicated that TRAIL might be used as an effective therapeutic modality for advanced metastatic cancers overexpressing c-Myc. This evidence concerns the gene TNFSF10 and metastatic malignant neoplasm.